5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)naphthalen-2-ol

Catalog No. :
ACDFPX675
CAS No. :
2323577-75-7
Molecular Formula :
C16H19BO3
Molecular Weight :
270.14

IUPAC Name:5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)naphthalen-2-ol

5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)naphthalen-2-ol structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$138.00Login to see priceIn stockInquiry
250mg98%$236.00Login to see priceIn stockInquiry
1g98%$651.00Login to see priceIn stockInquiry
5g98%$2767.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)naphthalen-2-ol
IUPAC Name5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)naphthalen-2-ol
Molecular FormulaC16H19BO3
Molecular Weight270.14
SMILESOC1=CC=C2C(B3OC(C)(C)C(C)(C)O3)=CC=CC2=C1
InChI KeyQUIUGSYQDHBANQ-UHFFFAOYSA-N
Synonym2-Naphthalenol, 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-;5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)naphthalen-2-ol
CAS No.2323577-75-7

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACDFPX675 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  2. Plus
  3. ACUBER304 route compound structure diagram
    ACUBER304116632-05-4 In Stock
  4. Then
  5. ACDFPX675 route product structure diagram
    ACDFPX6752323577-75-7 In Stock
Inquiry

2. ACDFPX675 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACDFPX675 route product structure diagram
    ACDFPX6752323577-75-7 In Stock
Inquiry

Comments (0)